MEI Pharma Inc (MEIP) — Cash Flow Reinvestment Rate

Latest as of December 2020: 1.27x

MEI Pharma Inc (MEIP) has a Cash Flow Reinvestment Rate of 1.27x as of December 2020, reinvesting $5.14 Million (capex $56.00K plus investments $-5.09 Million) from operating cash flow of $4.05 Million. See MEI Pharma Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.27x
(Capex + Investments) / Operating CF

Total Reinvested

$5.14 Million
Capex + Investments

Operating Cash Flow

$4.05 Million
USD

Capital Expenditures

$56.00K
USD

MEI Pharma Inc Cash Flow Reinvestment Rate (2017–2020)

Historical reinvestment intensity for MEI Pharma Inc across 2 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of MEI Pharma Inc.

Annual Cash Flow Reinvestment Rate for MEI Pharma Inc (2017–2020)

Year-by-year capital reinvestment analysis for MEI Pharma Inc. See MEIP financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2020 3.10x $106.29 Million $34.26 Million $894.00K ▲ +7.3%
2017 2.89x $10.08 Million $3.49 Million $51.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow